Company Dumimed Srl with Fiscal Code 16094036
recorded a turnover of 2024 of
111.739,
with a net profit of
60.443
and having an average number of employees of
3.
The company operates in the field of Activităţi de asistenţă medicală generală having the NACE code 8621.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Dumimed Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
38.558
41.920
43.773
51.117
62.303
71.587
77.938
84.354
101.751
111.739
Total Income - EUR
38.558
41.920
44.868
51.118
62.303
71.588
77.939
84.355
101.752
111.741
Total Expenses - EUR
15.521
17.954
18.717
18.965
31.279
34.360
34.640
37.520
42.625
47.946
Gross Profit/Loss - EUR
23.037
23.966
26.151
32.153
31.025
37.228
43.299
46.836
59.127
63.795
Net Profit/Loss - EUR
21.879
23.547
25.656
31.642
30.402
36.512
42.520
45.992
58.110
60.443
Employees
3
3
2
2
3
3
3
3
3
3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 10.4%, from 101.751 euro in the year 2023, to 111.739 euro in 2024.
The Net Profit increased by 2.658 euro, from 58.110 euro in 2023, to 60.443 in the last year.
Check the financial reports for the company - Dumimed Srl
Financial Rating - DUMIMED SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Dumimed Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Dumimed Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Dumimed Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
61.489 euro in 2024 which includes Inventories of
0 euro, Receivables of
45.070 euro and cash availability of
16.419 euro.
The company's Equity was valued at
66.475 euro, while total Liabilities amounted to
3.602 euro.
Equity increased by 2.658 euro, from 64.176 euro in 2023, to 66.475 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Dumimed Srl